Cisatracurium Besylate Injection, Solution
Product Images NDC 71288-714

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Cisatracurium Besylate (NDC 71288-714). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel – Cisatracurium Besylate Injection, Usp – 5 mL Carton (Cis Ht 10mg Carton)

FDA Label Image

Principal Display Panel – Cisatracurium Besylate Injection, Usp – 5 mL Vial Label (Cis Ht 10mg Vial)

This text appears to be the product information for Cisatracur Besylate Injection, USP. It includes details such as the manufacturer (Meitheal Pharmaceuticals Inc.), copyright year (©2023), dosage strength (2 mg per mL), usage warning (Paralyzing Agent), and packaging information (5 mL Single-Dose Vial). The product is meant for intravenous injection and is available under the NDC code 71288-712-95. Please note that the text also contains a warning in the form of "Rx Only".*

FDA Label Image

Principal Display Panel – Cisatracurium Besylate Injection, Usp – 20 mL Carton (Cis Ht 200mg Carton)

FDA Label Image

Principal Display Panel – Cisatracurium Besylate Injection, Usp – 20 mL Vial Label (Cis Ht 200mg Vial)

This text shows details of a prescription medication labeled as Cisatracurium Besylate Injection, USP. It is intended for intravenous injection for use in the intensive care unit (ICU) only. The dosage strength is indicated as 20 milligrams per milliliter (mg/mL) in a single-dose vial. The medication is a paralyzing agent, and cautionary statements are provided. The contact information for the pharmaceutical company, Meitheal Pharmaceuticals, based in Chicago, IL, is also included.*

FDA Label Image

Principal Display Panel – Cisatracurium Besylate Injection, Usp – 10 mL Carton (Cis Ht 20mg Carton)

FDA Label Image

Principal Display Panel – Cisatracurium Besylate Injection, Usp – 10 mL Vial Label (Cis Ht 20mg Vial)

This is a prescription medication called Clatractracurium Besylate Injection (brand name Greg) with a warning that it is a paralyzing agent intended for intravenous injection. It is a 2 mg per ml solution containing 0.9% benzylalcohol as a preservative. The medication comes in a 10 mL multi-dose vial and should be stored refrigerated at 2° to 8°C (36° to 46°F) and protected from light. Once removed from refrigeration, it should be used within 21 days even if re-refrigerated. The medication should be discarded after a certain date and is manufactured for Meitheal Pharmaceuticals in the USA.*

FDA Label Image

Figure 1 (Cis Ht Fig1)

This text appears to represent percentage changes, with an increase of 60% over 4 hours, a range of -60% to +60%, and a decrease of 60%. It may indicate changes in values or quantities over a specified time frame.*

FDA Label Image

Figure 2 (Cis Ht Fig2)

FDA Label Image

Structural Formula (Cis Ht Struct)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.